Effect of compounds on a spectrum of rat tumors.
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy; D000477:Alkylating Agents / Q000627:therapeutic use; D000577:Amides / Q000627:therapeutic use; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy; D005492:Folic Acid / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy; D008113:Liver Neoplasms; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011687:Purines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D051381:Rats; D012509:Sarcoma / Q000188:drug therapy; D012517:Sarcoma, Yoshida / Q000188:drug therapy; D013256:Steroids / Q000627:therapeutic use
D000477:Alkylating Agents; D000577:Amides; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D011687:Purines; D011743:Pyrimidines; D011804:Quinolines; D013256:Steroids; D005492:Folic Acid